The University’s Professor Sir Munir Pirmohamed has received an Outstanding Contribution award from Bionow, a not for profit membership organisation supporting the biomedical, pharma and life sciences sectors across the North of England.
He was presented with the award, specially selected by the judging panel, at the Bionow Awards digital ceremony on 4th February. The award, sponsored by Sci-Tech Daresbury and the Science and Technology Facilities Council, recognises Professor Sir Pirmohamed’s significant contribution to health and life sciences in the region.
The 2020 Bionow Awards aimed to bring the sector together, recognise the outstanding success and achievements of those who have worked tirelessly this year and spotlight the incredible progress that has been made during this challenging period.
Professor Sir Pirmohamed, also Consultant Physician at the Royal Liverpool University Hospital, holds the only NHS Chair in Pharmacogenetics in the UK and is Director of the Medical Research Council’s Centre for Drug Safety Science.
Professor Sir Pirmohamed’s research, which spans the whole spectrum from discovery to implementation, focuses on individual variability in drug response, including anti-cancer drugs, with a view to evaluating the mechanisms and identifying strategies to personalise healthcare.
As Director of the Wolfson Centre for Personalised Medicines at Liverpool, Professor Sir Pirmohamed has pioneered major new initiatives to establish a clinical evidence base for safe and effective medication based on a patient’s unique genetic make-up, age, weight and diet.
In his role as Chair of the Commission on Human Medicines Expert Working Group, he has been deeply involved in advising government on the quality, safety and efficacy of COVID-19 vaccines.
Our interdisciplinary world-leading research, unique model for collaboration and cutting-edge facilities enable our academic community to work with external organisations to create global solutions aiming to improve health, create wealth and ensure social justice. Discover more here.